Cargando…

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

Zoonotic pandemics, such as that caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can follow the spillover of animal viruses into highly susceptible human populations. The descendants of these viruses have adapted to the human host and evolved to evade immune pressure. Coronav...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, Kevin R., Rennick, Linda J., Nambulli, Sham, Robinson-McCarthy, Lindsey R., Bain, William G., Haidar, Ghady, Duprex, W. Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971772/
https://www.ncbi.nlm.nih.gov/pubmed/33536258
http://dx.doi.org/10.1126/science.abf6950
_version_ 1783666652012871680
author McCarthy, Kevin R.
Rennick, Linda J.
Nambulli, Sham
Robinson-McCarthy, Lindsey R.
Bain, William G.
Haidar, Ghady
Duprex, W. Paul
author_facet McCarthy, Kevin R.
Rennick, Linda J.
Nambulli, Sham
Robinson-McCarthy, Lindsey R.
Bain, William G.
Haidar, Ghady
Duprex, W. Paul
author_sort McCarthy, Kevin R.
collection PubMed
description Zoonotic pandemics, such as that caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can follow the spillover of animal viruses into highly susceptible human populations. The descendants of these viruses have adapted to the human host and evolved to evade immune pressure. Coronaviruses acquire substitutions more slowly than other RNA viruses. In the spike glycoprotein, we found that recurrent deletions overcome this slow substitution rate. Deletion variants arise in diverse genetic and geographic backgrounds, transmit efficiently, and are present in novel lineages, including those of current global concern. They frequently occupy recurrent deletion regions (RDRs), which map to defined antibody epitopes. Deletions in RDRs confer resistance to neutralizing antibodies. By altering stretches of amino acids, deletions appear to accelerate SARS-CoV-2 antigenic evolution and may, more generally, drive adaptive evolution.
format Online
Article
Text
id pubmed-7971772
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-79717722021-03-24 Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape McCarthy, Kevin R. Rennick, Linda J. Nambulli, Sham Robinson-McCarthy, Lindsey R. Bain, William G. Haidar, Ghady Duprex, W. Paul Science Reports Zoonotic pandemics, such as that caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can follow the spillover of animal viruses into highly susceptible human populations. The descendants of these viruses have adapted to the human host and evolved to evade immune pressure. Coronaviruses acquire substitutions more slowly than other RNA viruses. In the spike glycoprotein, we found that recurrent deletions overcome this slow substitution rate. Deletion variants arise in diverse genetic and geographic backgrounds, transmit efficiently, and are present in novel lineages, including those of current global concern. They frequently occupy recurrent deletion regions (RDRs), which map to defined antibody epitopes. Deletions in RDRs confer resistance to neutralizing antibodies. By altering stretches of amino acids, deletions appear to accelerate SARS-CoV-2 antigenic evolution and may, more generally, drive adaptive evolution. American Association for the Advancement of Science 2021-03-12 2021-02-03 /pmc/articles/PMC7971772/ /pubmed/33536258 http://dx.doi.org/10.1126/science.abf6950 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reports
McCarthy, Kevin R.
Rennick, Linda J.
Nambulli, Sham
Robinson-McCarthy, Lindsey R.
Bain, William G.
Haidar, Ghady
Duprex, W. Paul
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
title Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
title_full Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
title_fullStr Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
title_full_unstemmed Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
title_short Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
title_sort recurrent deletions in the sars-cov-2 spike glycoprotein drive antibody escape
topic Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971772/
https://www.ncbi.nlm.nih.gov/pubmed/33536258
http://dx.doi.org/10.1126/science.abf6950
work_keys_str_mv AT mccarthykevinr recurrentdeletionsinthesarscov2spikeglycoproteindriveantibodyescape
AT rennicklindaj recurrentdeletionsinthesarscov2spikeglycoproteindriveantibodyescape
AT nambullisham recurrentdeletionsinthesarscov2spikeglycoproteindriveantibodyescape
AT robinsonmccarthylindseyr recurrentdeletionsinthesarscov2spikeglycoproteindriveantibodyescape
AT bainwilliamg recurrentdeletionsinthesarscov2spikeglycoproteindriveantibodyescape
AT haidarghady recurrentdeletionsinthesarscov2spikeglycoproteindriveantibodyescape
AT duprexwpaul recurrentdeletionsinthesarscov2spikeglycoproteindriveantibodyescape